Morgan Stanley Pro Phase Labs, Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Morgan Stanley holds 9,166 shares of PRPH stock, worth $3,299. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,166

Previous 9,166 -0.0%

Holding current value

$3,299

Previous $6,000 50.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.61 - $2.47 $2,918 - $11,816	4,784 Added 109.17%	9,166 $6,000
Q2 2024 May 14, 2025	SELL	$4.18 - $7.35 $19,997 - $35,162	-4,784 Reduced 52.19%	4,382 $18,000
Q2 2024 Oct 17, 2024	BUY	$4.18 - $7.35 $8 - $14	2 Added 0.05%	4,382 $18,000
Q2 2024 Aug 14, 2024	BUY	$4.18 - $7.35 $8 - $14	2 Added 0.05%	4,382 $18,000
Q1 2024 Oct 17, 2024	SELL	$4.47 - $6.47 $8 - $12	-2 Reduced 0.05%	4,380 $28,000
Q1 2024 Aug 16, 2024	SELL	$4.47 - $6.47 $3,576 - $5,176	-800 Reduced 15.44%	4,380 $28,000
Q1 2024 May 15, 2024	SELL	$4.47 - $6.47 $3,576 - $5,176	-800 Reduced 15.44%	4,380 $28,000
Q4 2023 Aug 16, 2024	BUY	$4.35 - $5.1 $3,471 - $4,069	798 Added 18.21%	5,180 $23,000
Q4 2023 Feb 13, 2024	BUY	$4.35 - $5.1 $1,087 - $1,275	250 Added 5.07%	5,180 $23,000
Q3 2023 Nov 15, 2023	SELL	$4.23 - $7.53 $1,793 - $3,192	-424 Reduced 7.92%	4,930 $21,000
Q2 2023 Aug 14, 2023	BUY	$7.15 - $9.78 $357 - $488	50 Added 0.94%	5,354 $38,000
Q1 2023 May 15, 2023	SELL	$6.62 - $9.57 $62,088 - $89,757	-9,379 Reduced 63.88%	5,304 $40,000
Q4 2022 Feb 14, 2023	BUY	$8.78 - $12.47 $43,417 - $61,664	4,945 Added 50.78%	14,683 $141,000
Q3 2022 Nov 14, 2022	BUY	$8.96 - $14.7 $1,576 - $2,587	176 Added 1.84%	9,738 $110,000
Q2 2022 Oct 27, 2022	BUY	$6.52 - $13.24 $43,514 - $88,363	6,674 Added 231.09%	9,562 $121,000
Q2 2022 Aug 15, 2022	BUY	$6.52 - $13.24 $43,514 - $88,363	6,674 Added 231.09%	9,562 $121,000
Q1 2022 Oct 27, 2022	SELL	$6.2 - $7.87 $41,378 - $52,524	-6,674 Reduced 69.8%	2,888 $20,000
Q1 2022 May 13, 2022	SELL	$6.2 - $7.87 $20,701 - $26,277	-3,339 Reduced 53.62%	2,888 $20,000
Q4 2021 Feb 14, 2022	SELL	$5.13 - $7.89 $20,966 - $32,246	-4,087 Reduced 39.63%	6,227 $45,000
Q3 2021 Nov 15, 2021	BUY	$4.89 - $7.82 $50,435 - $80,655	10,314 New	10,314 $54,000

Others Institutions Holding PRPH

# of Institutions

Shares Held

4.95M

Call Options Held

Put Options Held

View Full List

About ProPhase Labs, Inc.

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $5.77M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

More about PRPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account